K
KulrMeStoopid
Guest
The recent decision by the UK medicines and healthcare products regulatory agency (MHRA) to regulate electronic cigarettes as medicinal products is good news for manufacturers of real cigarettes and nicotine patches, but not so much for Britain’s growing number of e-cigarette users, now estimated to exceed one million. No one denies that e-cigarettes should meet basic standards of safety and quality, but there are enough consumer-protection laws in place already without forcing this patently non-medical product down the pharmaceutical route.
The MHRA’s justification for medicalising e-cigarettes is that most vapers (e-cigarette enthusiasts) use them to quit or reduce their smoking. ‘This’, the MHRA says, ‘is comparable to how nicotine replacement products (eg, gums, patches, inhalator), which are licensed as medicines, are used’. This is fallacious logic.
Pharmaceutical nicotine products are licensed medicines because pharmaceutical companies needed them to be viewed as such before they could be marketed as cessation aids and prescribed by doctors. There is no other precedent for medicalising products that might help people to quit smoking, whether they contain nicotine (eg, snuff) or are merely substitutes for a habit (eg, chewing gum). Medical approval was a commercial necessity for the pharmaceutical industry, but it is neither necessary nor appropriate for e-cigarettes. No one would expect skimmed milk and Special K to be licensed as medicines just because the anti-obesity drug Alli went down that route, although all of them can be used to help people lose weight.
Chris Snowdon is the author of The Art of Suppression: Pleasure, Panic and Prohibition Since 1800
http://www.spiked-online.com/newsite/article/13718/#.UlFOTlAm6d6